Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.
Link :
https://www.wired.com/story/telehealth-pivot-liraglutide-fda-shortage/
Link :
https://www.wired.com/story/telehealth-pivot-liraglutide-fda-shortage/